BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21045149)

  • 1. Tumor-initiating function of nucleostemin-enriched mammary tumor cells.
    Lin T; Meng L; Li Y; Tsai RY
    Cancer Res; 2010 Nov; 70(22):9444-52. PubMed ID: 21045149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.
    Tamase A; Muraguchi T; Naka K; Tanaka S; Kinoshita M; Hoshii T; Ohmura M; Shugo H; Ooshio T; Nakada M; Sawamoto K; Onodera M; Matsumoto K; Oshima M; Asano M; Saya H; Okano H; Suda T; Hamada J; Hirao A
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17163-8. PubMed ID: 19805150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression.
    Lin T; Lin TC; McGrail DJ; Bhupal PK; Ku YH; Zhang W; Meng L; Lin SY; Peng G; Tsai RYL
    Oncogene; 2019 May; 38(20):3919-3931. PubMed ID: 30692636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo.
    Hebbard LW; Maurer J; Miller A; Lesperance J; Hassell J; Oshima RG; Terskikh AV
    Cancer Res; 2010 Nov; 70(21):8863-73. PubMed ID: 20861186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
    Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
    Morrison BJ; Steel JC; Morris JC
    PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.
    Ahmed F; Wyckoff J; Lin EY; Wang W; Wang Y; Hennighausen L; Miyazaki J; Jones J; Pollard JW; Condeelis JS; Segall JE
    Cancer Res; 2002 Dec; 62(24):7166-9. PubMed ID: 12499251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
    Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
    Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
    Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
    Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
    Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
    Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.
    Shin DH; Park JH; Lee JY; Won HY; Jang KS; Min KW; Jang SH; Woo JK; Oh SH; Kong G
    Oncotarget; 2015 Jul; 6(19):17276-90. PubMed ID: 25938540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.